Key result
Catheter ablation of fascicular ventricular tachycardia guided by activation mapping achieved an 80.3% single procedural success rate, with shorter VT cycle length predicting recurrence (P=0.03).
Why the study?
Does radiofrequency ablation guided by activation mapping prevent arrhythmia recurrence in patients with fascicular ventricular tachycardia?
Cohort (n=120)
No
Does radiofrequency ablation guided by activation mapping prevent arrhythmia recurrence in patients with fascicular ventricular tachycardia?
Activation mapping-guided radiofrequency ablation for fascicular ventricular tachycardia is highly effective long-term, with a single-procedure success rate of 80.3% without antiarrhythmic drugs.
May support activation mapping-guided ablation in fascicular VT; leaves open recurrence prevention versus alternatives in randomized trials.
BACKGROUND: Fascicular ventricular tachycardia (FVT) is a common form of sustained idiopathic left ventricular tachycardia with an Asian preponderance. This study aimed to prospectively investigate long-term clinical outcomes of patients undergoing ablation of FVT and identify predictors of arrhythmia recurrence. METHODS AND RESULTS: Consecutive patients undergoing FVT ablation at a single tertiary center were enrolled. Activation mapping was performed to identify the earliest presystolic Purkinje potential during FVT that was targeted by radiofrequency ablation. Follow-up with clinic visits, ECG, and Holter monitoring was performed at least every 6 months. A total of 120 consecutive patients (mean age, 29.3±12.7 years; 82% men; all patients with normal ejection fraction) were enrolled. FVT involved left posterior fascicle and left anterior fascicle in 118 and 2 subjects, respectively. VT was noninducible in 3 patients, and ablation was acutely successful in 117 patients. With a median follow-up of 55.7 months, VT of a similar ECG morphology recurred in 17 patients, and repeat procedure confirmed FVT recurrence involving the same fascicle. Shorter VT cycle length was the only significant predictor of FVT recurrence (P=0.03). Six other patients developed new-onset upper septal FVT that was successfully ablated. CONCLUSIONS: Ablation of FVT guided by activation mapping is associated with a single procedural success rate without the use of antiarrhythmic drugs of 80.3%. Arrhythmia recurrences after an initially successful ablation were caused by recurrent FVT involving the same fascicle in two thirds of patients or new onset of upper septal FVT in the remainder.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2015) conducted a cohort in Fascicular ventricular tachycardia (n=120). Catheter ablation guided by activation mapping was evaluated on Single procedural success rate without antiarrhythmic drugs. Catheter ablation of fascicular ventricular tachycardia guided by activation mapping achieved an 80.3% single procedural success rate, with shorter VT cycle length predicting recurrence (P=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: